Acquired Resistance to Endocrine Treatments Is Associated with Tumor-Specific Molecular Changes in Patient-Derived Luminal Breast Cancer Xenografts-Reference-Cited by-同舟云学术

Acquired Resistance to Endocrine Treatments Is Associated with Tumor-Specific Molecular Changes in Patient-Derived Luminal Breast Cancer Xenografts

Published:2014-06-19 Issue:16 Volume:20 Page:4314-4325
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Cottu Paul,Bièche Ivan,Assayag Franck,El Botty Rania,Chateau-Joubert Sophie,Thuleau Aurélie,Bagarre Thomas,Albaud Benoit,Rapinat Audrey,Gentien David,de la Grange Pierre,Sibut Vonick,Vacher Sophie,Hatem Rana,Servely Jean-Luc,Fontaine Jean-Jacques,Decaudin Didier,Pierga Jean-Yves,Roman-Roman Sergio,Marangoni Elisabetta

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER ⁺ breast cancer;Science Translational Medicine;2024-02-28

2. Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα⁺ breast cancer;EMBO Molecular Medicine;2023-07-17

3. SERPINA3-ANKRD11-HDAC3 pathway induced aromatase inhibitor resistance in breast cancer can be reversed by HDAC3 inhibition;Communications Biology;2023-07-06

4. HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers;Molecular Oncology;2023-03-23

5. Her2/EGFR-PDGFR pathway aberrations associated with tamoxifen response in metastatic breast cancer patients;Journal of the Egyptian National Cancer Institute;2022-07-25